ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
Early identification and referral of liver disease in infants
This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate.
NICE CKS—cow’s milk allergy in children
Be aware that the clinical features of cow’s milk allergy are variable in type and severity and can overlap with other common conditions, so clinical judgement is needed when interpreting symptoms.
NICE ADHD guideline
The updated summary covers key points on identification and treatment of ADHD, management, supporting families and carers, and appropriate medication.
NICE bronchiolitis guideline
A brief summary of the NICE guideline on bronchiolitis in children including advice on when to refer, and 'red flags' for parents to watch out for at home.
NICE fever in under 5s guideline
A summary of the 2019 updated NICE guideline on fever in under 5s with a ‘traffic light’ approach to assessing risk, and features of specific diseases
SIGN FASD guideline
Failure to recognise prenatal alcohol exposure as a possible cause of behavioural difficulties may contribute to adverse outcomes for the child.
PHE scarlet fever guideline
A concise summary of the PHE guideline on the management of scarlet fever and its complications, and the recommended actions to effectively treat them
PHE whooping cough guideline
Summary of PHE guidance on the management of whooping cough covers testing and includes an algorithm on the management of patients with the condition.
Let’s talk about weight in children guideline
This summary relates to families of 4–12-year-old children and young people, covering how to discuss weight, and support positive lifestyle changes.
Resource hub
Educational resources
Use of unlicensed medicines in paediatric patients guideline
This guideline was developed by a multidisciplinary expert panel: Tomlin S et al with the support of a grant from Rosemont Pharmaceuticals Ltd.